Items where Author is "Zajac, P."

2022

Bart, N. and Dangel, C. and Zajac, P. and Spitzer, N. and Ritzmann, J. and Schmidt, M. and Babin, H. G. and Schott, R. and Valentin, S. R. and Scholz, S. and Wang, Y. and Uppu, R. and Najer, D. and Loebl, M. C. and Tomm, N. and Javadi, A. and Antoniadis, N. O. and Midolo, L. and Mueller, K. and Warburton, R. J. and Lodahl, P. and Wieck, A. D. and Finley, J. J. and Ludwig, A.. (2022) Wafer-scale epitaxial modulation of quantum dot density. Nature Communications, 13 (1). p. 1633.

2015

Bocelli-Tyndall, C. and Trella, E. and Frachet, A. and Zajac, P. and Pfaff, D. and Geurts, J. and Heiler, S. and Barbero, A. and Mumme, M. and Resink, T. J. and Schaeren, S. and Spagnoli, G. C. and Tyndall, A.. (2015) FGF2 induces RANKL gene expression as well as IL1beta regulated MHC class II in human bone marrow-derived mesenchymal progenitor stromal cells. Annals of the rheumatic diseases, Vol. 74, H. 1. pp. 260-266.

2012

Raafat, N. and Sadowski-Cron, C. and Mengus, C. and Heberer, M. and Spagnoli, G. C. and Zajac, P.. (2012) Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope. International journal of cancer, Vol. 131, H. 5 , S. E659-E669.

2011

Schultz-Thater, E. and Piscuoglio, S. and Iezzi, G. and Le Magnen, C. and Zajac, P. and Carafa, V. and Terracciano, L. and Tornillo, L. and Spagnoli, G. C.. (2011) MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies. International journal of cancer, Vol. 129, H. 5. pp. 1137-1148.

2009

Zajac, P.. (2009) Non-replicating recombinant vaccinia virus expressing CD80 to enhance T-cell stimulation. Methods in Molecular Biology, Vol. 514. pp. 151-162.

2008

Bracci, L. and Schumacher, R. and Provenzano, M. and Adamina, M. and Rosenthal, R. and Groeper, C. and Zajac, P. and Iezzi, G. and Proietti, E. and Belardelli, F. and Spagnoli, G. C.. (2008) Efficient stimulation of T cell responses by human IFN-alpha-induced dendritic cells does not require Toll-like receptor triggering. Journal of immunotherapy, Vol. 31, H. 5. pp. 466-474.

Adamina, M. and Weber, W. P. and Rosenthal, R. and Schumacher, R. and Zajac, P. and Guller, U. and Frey, D. M. and Oertli, D. and Zuber, M. and Heberer, M. and Spagnoli, G. C.. (2008) Heterologous prime-boost immunotherapy of melanoma patients with Influenza virosomes, and recombinant Vaccinia virus encoding 5 melanoma epitopes and 3 co-stimulatory molecules : a multi-centre phase I/II open labeled clinical trial. Contemp Clin Trials, Vol. 29. pp. 165-181.

Schultz-Thater, E. and Frey, D. M. and Margelli, D. and Raafat, N. and Feder-Mengus, C. and Spagnoli, G. C. and Zajac, P.. (2008) Whole blood assessment of antigen specific cellular immune response by real time quantitative PCR : a versatile monitoring and discovery tool. Journal of translational medicine, Vol. 6. p. 58.

2007

Feder-Mengus, C. and Ghosh, S. and Weber, W. P. and Wyler, S. and Zajac, P. and Terracciano, L. and Oertli, D. and Heberer, M. and Martin, I. and Spagnoli, G. C. and Reschner, A.. (2007) Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytes. British journal of cancer, 96 (7). pp. 1072-1082.